Melissa Epperly - Insider Trading & Ownership

Entity
Individual
Location
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, New York
Summary
The estimated net worth of Melissa Epperly is at least $5.42M dollars as of July 25, 2024. Melissa Epperly is the Chief Financial Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $5.16M. Melissa Epperly is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $256K.
All Insider Reports
All Insider Reports

Ownership of Melissa Epperly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Chief Financial Officer $5.16M -$236K -4.38% Feb 12, 2024
ROIV Roivant Sciences Ltd. Director $256K Jul 23, 2024
KNTE Kinnate Biopharma Inc. Director Apr 3, 2024
NAUT Nautilus Biotechnology, Inc. Director Jun 14, 2024

Insider Transactions Reported by Melissa Epperly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.